Results for "The Role of Distributors in the U.S. Specialty Pharmaceuticals Value Chain"
Cowman and O’Dowd To Lead HDA Research Foundation Board of Directors
The HDA Research Foundation announced Craig Cowman of Cardinal Health as Chairman of its Board of Directors. Stephen O’Dowd of Eisai, Inc., is Vice Chairman.
FDA, Industry Experts Urge DSCSA Action at HDA’s 2023 Traceability Seminar
HDA convened more than 400 healthcare supply chain stakeholders, technology experts and regulatory officials for the association’s Traceability Seminar. This highly anticipated event provided a forum to discuss implementation challenges and strategies for Drug Supply Chain Security Act (DSCSA) compliance as the industry faced a November 27, 2023, deadline to establish a framework to trace pharmaceuticals across the supply chain.
HDA Statement on FDA’s Phased Exemption for Eligible Trading Partners from the DSCSA’s Final Implementation Requirements
HDA released a statement from President and CEO Chester “Chip” Davis, Jr., on the Food and Drug Administration’s (FDA) issuing of an exemption for eligible trading partners to comply with the final requirements of the Drug Supply Chain Security Act (DSCSA).
HDA Research Foundation Names Apotex and Anda Executives To Lead Board of Directors
The HDA Research Foundation announced Steve Giuli of Apotex Corp. as Chairman of its Board of Directors. Anthony Mihelich of Anda, Inc., was named Vice Chairman.